BCAX
Bicara Therapeutics
BCAX
BCAX
84 hedge funds and large institutions have $814M invested in Bicara Therapeutics in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
19% more ownership
Funds ownership: 66.83% → 85.83% (+19%)
12% less capital invested
Capital invested by funds: $926M → $814M (-$112M)
Holders
84
Holding in Top 10
7
Calls
$22K
Puts
–
Top Buyers
| 1 | +$24M | |
| 2 | +$22M | |
| 3 | +$21M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.8M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.28M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$9.47M | |
| 3 | -$5.96M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$5.64M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$5.09M |